1. Home
  2. AMPH vs GSBD Comparison

AMPH vs GSBD Comparison

Compare AMPH & GSBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

N/A

Current Price

$28.25

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Logo Goldman Sachs BDC Inc.

GSBD

Goldman Sachs BDC Inc.

N/A

Current Price

$7.69

Market Cap

943.9M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
AMPH
GSBD
Founded
1996
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
943.9M
IPO Year
2005
2013

Fundamental Metrics

Financial Performance
Metric
AMPH
GSBD
Price
$28.25
$7.69
Analyst Decision
Hold
Sell
Analyst Count
7
5
Target Price
★ $24.50
$8.63
AVG Volume (30 Days)
433.1K
★ 814.9K
Earning Date
11-05-2026
11-05-2026
Dividend Yield
N/A
★ 17.18%
EPS Growth
N/A
★ 87.27
EPS
★ 1.67
0.05
Revenue
★ $719,887,000.00
N/A
Revenue This Year
$3.81
N/A
Revenue Next Year
$4.91
N/A
P/E Ratio
★ $16.84
$156.00
Revenue Growth
N/A
★ N/A
52 Week Low
$16.65
$7.70
52 Week High
$31.00
$10.38

Technical Indicators

Market Signals
Indicator
AMPH
GSBD
Relative Strength Index (RSI) 54.84 22.22
Support Level $24.37 N/A
Resistance Level $29.23 $9.08
Average True Range (ATR) 1.26 0.22
MACD -0.08 -0.08
Stochastic Oscillator 36.22 0.36

Price Performance

Historical Comparison
AMPH
GSBD

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.

About GSBD Goldman Sachs BDC Inc.

Goldman Sachs BDC Inc is a non-diversified, closed-end management investment company that elected to be regulated as a business development company focused on lending to middle-market companies. The investment objective is to generate current income and, to a lesser extent, capital appreciation through direct originations of secured debt, including the first lien, unitranche and second lien debt, and unsecured debt. It invests in U.S. middle-market companies such as banks and the public debt markets. The company focuses on the negotiation and structuring of the loans or securities in which it invests and holding the investments in its portfolio to maturity. It generates majority revenue in the form of interest income and dividend income.

Share on Social Networks: